Clearance Summary
IMX HOMOCYSTEINE received FDA 510(k) clearance under submission number K980812, sponsored by Axis Biochemicals, Asa. The device was reviewed via the Traditional premarket notification pathway and assigned to the Immunology review panel. The statutory decision date of record is 1998-10-01.
- Submission: K980812
- Applicant / Sponsor: Axis Biochemicals, Asa
- Clearance pathway: Traditional
- Review panel: Immunology
- Device class: Class II
- Regulation citation: 21 CFR 866.5600
- Decision date: 1998-10-01
Classification & Regulation
This clearance is catalogued under FDA product code DFC and 21 CFR 866.5600, within the Immunology review panel as a Class II device.